Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 16 matching records.
16 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Targeting CD44-Hyaluronic Acid Signalling in Obesity Treatment: Insights from Small Molecules and Nanobioconjugates
Narrative Review on Type 2 Diabetes, published in Nutr Metab Insights (2026) — summary generated from the PubMed abstract.
- 2026
Nutr Metab Insights - Level DNarrative ReviewEurope PMC
Obesity-Related Cognitive Impairment: An Update Overview of Mechanisms and Treatments
Narrative Review on Type 2 Diabetes, Neuroinflammation, published in Expert Rev Mol Med (2026) — summary generated from the PubMed abstract.
- 2026
Expert Rev Mol Med - Level DNarrative ReviewEurope PMC
Combined Hyaluronic Acid Nanobioconjugates Impair CD44-Signaling for Effective Treatment Against Obesity: A Review of Comparison with Other Actors
Narrative Review on Type 2 Diabetes, published in Int J Nanomedicine (2025) — summary generated from the PubMed abstract.
- 2025
Int J Nanomedicine4 citations - Level DNarrative ReviewEurope PMC
Cellular Senescence and Extracellular Vesicles in the Pathogenesis and Treatment of Obesity-A Narrative Review
Narrative Review on Type 2 Diabetes, published in Int J Mol Sci (2024) — summary generated from the PubMed abstract.
- 2024
Int J Mol Sci20 citations - Level DNarrative ReviewPubMed
Management of Obesity and Obesity-Related Disorders: From Stem Cells and Epigenetics to Its Treatment.
Narrative Review on Type 2 Diabetes, published in Int J Mol Sci (2023) — summary generated from the PubMed abstract.
- 2023
Int J Mol Sci6 citations - Level DLaboratory StudyEurope PMC
Cannabidiol treatment improves metabolic profile and decreases hypothalamic inflammation caused by maternal obesity
Laboratory Study on Type 2 Diabetes, Neuroinflammation, published in Front Nutr (2023) — summary generated from the PubMed abstract.
- 2023
Front Nutr13 citations - Level DAnimal StudyEurope PMC
Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes
Animal Study on Type 2 Diabetes, Chronic Inflammation, published in PLoS One (2022) — summary generated from the PubMed abstract.
- 2022
PLoS One2 citations - Level DAnimal StudyPubMed
Human adipose tissue mesenchymal stem cells as a novel treatment modality for correcting obesity induced metabolic dysregulation.
Animal Study on Type 2 Diabetes, published in Int J Obes (Lond) (2019) — summary generated from the PubMed abstract.
- 2019
Int J Obes (Lond) - Level ASystematic ReviewPubMed
Adipose-derived Mesenchymal Stem Cells in the Treatment of Obesity: A Systematic Review of Longitudinal Studies on Preclinical Evidence.
Systematic Review on Type 2 Diabetes, published in Curr Stem Cell Res Ther (2018) — summary generated from the PubMed abstract.
- 2018
Curr Stem Cell Res Ther18 citations - Level DAnimal StudyPubMed
Gene expression profiling in adipose tissue of Sprague Dawley rats identifies olfactory receptor 984 as a potential obesity treatment target.
Animal Study with a reported sample of 225 on Type 2 Diabetes, published in Biochem Biophys Res Commun (2018) — summary generated from the PubMed abstract.
- 2018
- n = 225
Biochem Biophys Res Commun9 citations - Level DAnimal StudyPubMed
Targeting IκB kinase β in Adipocyte Lineage Cells for Treatment of Obesity and Metabolic Dysfunctions.
Animal Study on Type 2 Diabetes, published in Stem Cells (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells27 citations - Level DNarrative ReviewEurope PMC
Effects of Saponins on Lipid Metabolism: A Review of Potential Health Benefits in the Treatment of Obesity
Narrative Review on Type 2 Diabetes, Chronic Inflammation, published in Molecules (2016) — summary generated from the PubMed abstract.
- 2016
Molecules121 citations - Level DNarrative ReviewEurope PMC
Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance
Narrative Review on Type 2 Diabetes, published in Front Physiol (2015) — summary generated from the PubMed abstract.
- 2015
Front Physiol148 citations - Level DNarrative ReviewEurope PMC
Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity
Narrative Review on Systemic / IV, published in Front Endocrinol (Lausanne) (2015) — summary generated from the PubMed abstract.
- 2015
Front Endocrinol (Lausanne)44 citations - Level BClinical TrialEurope PMC
Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity
Clinical Trial, published in Diabetes Metab Syndr Obes (2014) — summary generated from the PubMed abstract.
- 2014
Diabetes Metab Syndr Obes42 citations - Level DAnimal StudyPubMed
Treatment of obesity and diabetes in mice by transplant of gut cells engineered to produce leptin.
Animal Study on Hip, Systemic / IV, published in Mol Ther (2008) — summary generated from the PubMed abstract.
- 2008
Mol Ther
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406